![Alexander Meier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Alexander Meier is the founder of MONDOSANO GmbH.
He currently works as a Director at Genui GmbH since 2017.
Aktiva positioner av Alexander Meier
| Företag | Position | Start |
|---|---|---|
Genui GmbH
 Genui GmbH Investment ManagersFinance GENUI is an active manager which provides financing for buyouts, successions, growth capital requirements, as well as P2P (public to private) transactions. The firm invests in mid-sized companies located in German-speaking countries. It targets companies operating in various sectors and industries including retail/e-commerce, FinTech, logistics, and pharmaceuticals. | Privat kapitalinvesterare | 2017-09-01 |
Tidigare kända positioner av Alexander Meier
| Företag | Position | Slut |
|---|---|---|
MONDOSANO GmbH
 MONDOSANO GmbH Internet Software/ServicesTechnology Services Operates an Internet platform, which provides users access to clinical research and new therapies | Verkställande Direktör | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
5
Första gradens relationer
2
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 2 |
|---|---|
Genui GmbH
Genui GmbH Investment ManagersFinance GENUI is an active manager which provides financing for buyouts, successions, growth capital requirements, as well as P2P (public to private) transactions. The firm invests in mid-sized companies located in German-speaking countries. It targets companies operating in various sectors and industries including retail/e-commerce, FinTech, logistics, and pharmaceuticals. | Finance |
MONDOSANO GmbH
MONDOSANO GmbH Internet Software/ServicesTechnology Services Operates an Internet platform, which provides users access to clinical research and new therapies | Technology Services |
